Semaglutide Oral 500mcg x 25 tablets

Semaglutide is a synthetic GLP-1 receptor agonist studied for its interaction with incretin receptors involved in glucose metabolism and appetite signaling. Research evaluates its receptor-mediated metabolic regulatory pathways in controlled laboratory environments.

FDA Disclaimer: The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The products offered are not intended to diagnose, treat, cure, or prevent any disease. All products are intended for laboratory research use only and are not for human consumption.